Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.
Amandine Mveang NzoghePaulin N EssoneMarielle LebouenyAnicet Christel Maloupazoa SiawayaEliode Cyrien BonghoOfilia Mvoundza NdjindjiRotimi Myrabelle Avome HouechenouSelidji Todagbe AgnandjiJoel Fleury Djoba SiawayaPublished in: Immunity, inflammation and disease (2020)
Although the clinical relevance of the observed reactivity can only be speculated and needs to be investigated, the implication of this finding for coronavirus disease 2019 seroepidemiological survey and vaccines' clinical trials is critical.